dansylarginine n-(3-ethyl-1,5-pentanediyl)amide has been researched along with Deficiency, Factor II in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boissel, JP; Elion, J; Jandrot-Perrus, M; Josso, F; Rabiet, MJ | 1 |
| Henriksen, RA; Mann, KG; Nesheim, ME; Owen, WG | 1 |
2 other study(ies) available for dansylarginine n-(3-ethyl-1,5-pentanediyl)amide and Deficiency, Factor II
| Article | Year |
|---|---|
Thrombin Metz: characterization of the dysfunctional thrombin derived from a variant of human prothrombin.
Topics: Antithrombin III; Arginine; Blood Coagulation; Dansyl Compounds; Enzyme Activation; Fibrinopeptide A; Fibrinopeptide B; Heparin; Humans; Hypoprothrombinemias; Kinetics; Platelet Aggregation; Prothrombin; Thrombin | 1984 |
Identification of a congenital dysthrombin, thrombin Quick.
Topics: Antithrombin III; Arginine; Calcium; Chromatography, Gel; Dansyl Compounds; Electrophoresis, Polyacrylamide Gel; Factor VIII; Factor X; Factor Xa; Fibrinogen; Humans; Hypoprothrombinemias; Phospholipids; Thrombin | 1980 |